These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 19199227

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hemophagocytic lymphohistiocytosis: when the immune system runs amok.
    Janka G.
    Klin Padiatr; 2009 Sep; 221(5):278-85. PubMed ID: 19707989
    [Abstract] [Full Text] [Related]

  • 5. Hemophagoctic lymphohistiocytosis--recent concept.
    Bhattacharyya M, Ghosh MK.
    J Assoc Physicians India; 2008 Jun; 56():453-7. PubMed ID: 18822626
    [Abstract] [Full Text] [Related]

  • 6. An unusual cause of multiple organ dysfunction syndrome in the pediatric intensive care unit: hemophagocytic lymphohistiocytosis.
    Karapinar B, Yilmaz D, Balkan C, Akin M, Ay Y, Kvakli K.
    Pediatr Crit Care Med; 2009 May; 10(3):285-90. PubMed ID: 19433941
    [Abstract] [Full Text] [Related]

  • 7. Determination of an appropriate cut-off value for ferritin in the diagnosis of hemophagocytic lymphohistiocytosis.
    Lehmberg K, McClain KL, Janka GE, Allen CE.
    Pediatr Blood Cancer; 2014 Nov; 61(11):2101-3. PubMed ID: 24753034
    [Abstract] [Full Text] [Related]

  • 8. Serum ferritin is a cost-effective laboratory marker for hemophagocytic lymphohistiocytosis in the developing world.
    Switala JR, Hendricks M, Davidson A.
    J Pediatr Hematol Oncol; 2012 Apr; 34(3):e89-92. PubMed ID: 22322940
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*.
    Rajasekaran S, Kruse K, Kovey K, Davis AT, Hassan NE, Ndika AN, Zuiderveen S, Birmingham J.
    Pediatr Crit Care Med; 2014 Jun; 15(5):401-8. PubMed ID: 24583503
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The clinical spectrum and treatment options of macrophage activation syndrome in the pediatric age.
    Stabile A, Bertoni B, Ansuini V, La Torraca I, Sallì A, Rigante D.
    Eur Rev Med Pharmacol Sci; 2006 Jun; 10(2):53-9. PubMed ID: 16705949
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Hemophagocytic lymphohistiocytosis: diagnostic problems in pediatrics].
    Balwierz W, Czogała M, Pawińska-Wasikowska K, Cwiklińska M, Walicka-Soja K.
    Przegl Lek; 2010 Jun; 67(6):417-24. PubMed ID: 21344773
    [Abstract] [Full Text] [Related]

  • 19. Acute respiratory distress syndrome as an initial presentation of hemophagocytic lymphohistiocytosis after induction therapy for acute myeloid leukemia.
    Nishikawa T, Okamoto Y, Tanabe T, Shinkoda Y, Kodama Y, Kakihana Y, Goto M, Kawano Y.
    Pediatr Hematol Oncol; 2011 Apr; 28(3):244-8. PubMed ID: 21083362
    [Abstract] [Full Text] [Related]

  • 20. [Ferritin and soluble interleukin-2-receptor in the diagnosis of fever of unknown origin].
    Rademacher C, Hartmann D, Spiethoff A, Jakobs R.
    Dtsch Med Wochenschr; 2014 Jan; 139(1-2):23-7. PubMed ID: 24390846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.